Zhang et al. reported that fibrauretine in combination with ginsenosides significantly reduced the progression of Alzheimer's disease through upregulation of Bcl-2 and downregulation of activated caspases 3 and 9 [28]. This evidence concerns the gene CASP3 and early-onset autosomal dominant Alzheimer disease.